Trial intelligence / Profile preview

Gongxuining capsule for abnormal uterine bleeding

ChiCTR2300076585Phase 4Not yet recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Jul 2023
Countries
1
01

Overview

Phase 4, open-label trial of gongxuening in menstrual disorders (3 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Change in menstrual bleeding after treatment, Change in quality of life score after treatment and 4 more. Planned start Jul 2023; status: not yet recruiting.

02

Drugs

gongxuening
03

Conditions

menstrual disorders

Beyond the preview

Go deeper on ChiCTR2300076585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call